课题基金 / 基金详情

PLASMA CATECHOLAMINES AND SYMPATHETIC ACTIVITY IN CLINICAL HYPERTENSION

PLASMA CATECHOLAMINES AND SYMPATHETIC ACTIVITY IN CLINICAL HYPERTENSION
临床高血压中的血浆儿茶酚胺和交感神经活动
批准号:
4694562
负责人:
D S GOLDSTEIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

D S GOLDSTEIN的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have used concentrations of plasma catecholamines to indicate activity of the sympathetic nervous system (SNS) in patients with essential hypertension, orthostatic hypotension, the hyperdynamic circulatory state syndrome, or sympathectomies. We developed clinical methods to estimate synaptic cleft concentrations of norepinephrine (NE), the sympathetic neurotransmitter; neuronal NE uptake (Uptake-1); and regional NE removal. We used clonidine suppression testing to identify patients in whom increased SNS activity contributed to high blood pressure. Measurement of arterial and venous NE in sympathectomized and intact human limbs confirmed the validity of plasma NE to indicate SNS activity. Patients with idiopathic orthostatic hypotension had decreased Uptake-1 activity. Elevated plasma catecholamines, clonidine sensitivity, and excessive responsiveness to isoproterenol characterized a patient with hyperdynamic circulaion syndrome. The amount of release of endogenous NE during isoproterenol infusions may indicate pre-synaptic beta adrenoceptor responsiveness. Dopamine does not act as a natriuretic hormone.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
  • 批准号:
    7901216
  • 项目类别:
  • 资助金额:
    $7.8万
  • 财政年份:
    2009
  • 负责人:
    D S GOLDSTEIN
  • 依托单位:
BIOCHEMICAL METHODS FOR VASOACTIVE SUBSTANCES
COLLABORATIVE STUDIES OF NEUROENDOCRINE PHARMACOLOGY AND PHYSIOLOGY
SYMPATHOADRENAL AND CATECHOLAMINE FUNCTION IN HEALTH